We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 for the quarter ended as on 30.06.2024 along with the Auditors limited review reports thereon.
Kwality Pharmaceuticals: Board Meeting Outcome for Submission Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended On 30.06.2024
August 10, 2024
Download PDF
Kwality Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month